English
dc.contributor.author | Cirpan, T | |
dc.contributor.author | Akercan, F | |
dc.contributor.author | Terek, MC | |
dc.contributor.author | Kazandi, M | |
dc.contributor.author | Ozcakir, HT | |
dc.contributor.author | Giray, G | |
dc.contributor.author | Sagol, S | |
dc.date.accessioned | 2024-07-18T11:58:46Z | |
dc.date.available | 2024-07-18T11:58:46Z | |
dc.description.abstract | I R O G CANADA, INC | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/7468 | |
dc.language.iso | Article | |
dc.publisher | 0390-6663 | |
dc.subject | Objective: The aim of the study was to determine VEGF protein with immunohistochemical staining in placental bed biopsies of preeclamptic pregnancies in comparison to normal controls. Design: Prospective cohort Study. Methods: The placental bed biopsies were obtained from 12 patients with preeclapmsia and ten patients for a control group at the time of cesarean delivery. Tissue samples of the placental bed were examined for VEGF protein distribution with avidin-biotin-peroxidase immunohistochemistry. Two blinded histopathologists were asked to score each sample for the intensity of staining and the number of cells stained in a randomly selected HPF of each sample. The resulting H-score was computed as a product of intensity and percent of cells stained. Results: VEGF expression was significantly lower in both the myometrium and stroma of the preeclamptic group compared to the control group (77.2 +/- 25.4 vs 134 +/- 44.3, p = 0.007; 194.1 +/- 20.7 vs 170.2 +/- 17, p = 0.017, respectively). Conclusion: VEGF expression is significantly lower in placental bed biopsies of preeclamptic pregnancies. | |
dc.title | English | |
dc.type | ENDOTHELIAL GROWTH-FACTOR | |
dc.type | HYPERTENSIVE DISORDERS | |
dc.type | VASCULAR FUNCTION | |
dc.type | PREGNANCY | |
dc.type | ANGIOGENESIS | |
dc.type | TROPHOBLAST | |
dc.type | EXPRESSION | |
dc.type | RECEPTORS | |
dc.type | VASCULOGENESIS | |
dc.type | INVASION |